Back
Credit Acceptance Vs. NovoCure Industry Stock Comparison
Buy
69
CACC
Credit Acceptance
Last Price:
471.46
Seasonality Move:
7.2%
Buy
77
NVCR
NovoCure
Last Price:
28.80
Seasonality Move:
2.04%
Buy
69
Credit Acceptance (CACC)
is a Buy
Is Credit Acceptance a Buy, Sell or Hold?
- The current Credit Acceptance [CACC] share price is $481.91. The Score for CACC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- CACC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CACC Stock Price Chart
What is Credit Acceptance's stock price today?
-
The Credit Acceptance share price today is $481.91
The current trend is moderately bullish and CACC is experiencing slight buying pressure.
NVCR Stock Price Chart
CACC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.78 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | 6591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (433.8 - 477.54) | Buy |
| Bollinger Bands (100): | (427.54 - 519.36) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 84.56 | Buy |
| Chaikin Money Flow: | -690353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 22.01) | Buy |
| Bollinger Bands (100): | (15.44 - 20.28) | Buy |
CACC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 482.59 | Sell |
| 20-day SMA: | 460.61 | Buy |
| 50-day SMA: | 455.82 | Buy |
| 200-day SMA: | 498.38 | Sell |
| 8-day EMA: | 480.08 | Buy |
| 20-day EMA: | 467.66 | Buy |
| 50-day EMA: | 462.12 | Buy |
| 200-day EMA: | 482.29 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.45 | Buy |
| 20-day SMA: | 18.85 | Buy |
| 50-day SMA: | 17.12 | Buy |
| 200-day SMA: | 17.34 | Buy |
| 8-day EMA: | 23.1 | Buy |
| 20-day EMA: | 19.92 | Buy |
| 50-day EMA: | 18.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
Credit Acceptance Earnings Growth & CACC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.66 per share, and an increase next year of $5.48 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Credit Acceptance Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||